RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

225 hedge funds and large institutions have $3.14B invested in Ultragenyx Pharmaceutical in 2022 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 103 increasing their positions, 60 reducing their positions, and 40 closing their positions.

Holders
225
Holders Change
-6
Holders Change %
-2.6%
% of All Funds
3.63%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
35
Increased
103
Reduced
60
Closed
40
Calls
$18.3M
Puts
$16M
Net Calls
+$2.28M
Net Calls Change
-$641K

Top Buyers

1
RI
1
RTW Investments
New York
$184M
2
APM
2
Avidity Partners Management
Texas
$139M
3
SCM
3
Suvretta Capital Management
New York
$37.9M
4
Millennium Management
4
Millennium Management
New York
$35.8M
5
First Trust Advisors
5
First Trust Advisors
Illinois
$53M

Top Sellers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$18.6M
2
Capital International Investors
2
Capital International Investors
California
$60M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$241M
4
Federated Hermes
4
Federated Hermes
Pennsylvania
$143M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$190M
Name Holding Trade Value Shares
Change 		Shares
Change %
Bank of New York Mellon
26
Bank of New York Mellon
New York
$30.2M -$3.89M -83,966 -11%
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
$26.2M +$10.5M +226,000 +66%
FAM
28
Fred Alger Management
New York
$23M +$6.01M +129,827 +35%
BBA
29
Baker Bros. Advisors
New York
$21.8M – – –
Nuveen Asset Management
30
Nuveen Asset Management
Illinois
$21.5M +$12.1M +260,212 +127%
Two Sigma Advisers
31
Two Sigma Advisers
New York
$21.3M +$19M +409,300 +796%
Two Sigma Investments
32
Two Sigma Investments
New York
$20.5M +$8.64M +186,547 +73%
T. Rowe Price Investment Management
33
T. Rowe Price Investment Management
Maryland
$18.6M -$102M -2,204,910 -85%
Bank of America
34
Bank of America
North Carolina
$18.2M +$1.17M +25,198 +7%
Charles Schwab
35
Charles Schwab
California
$17.2M +$332K +7,168 +2%
EAM
36
Eventide Asset Management
Massachusetts
$16.6M +$2.46M +53,200 +17%
EA
37
Emerald Advisers
Pennsylvania
$16M -$109K -2,356 -0.7%
GPP
38
Great Point Partners
Connecticut
$15.9M +$15.9M +342,300 New
Marshall Wace
39
Marshall Wace
United Kingdom
$15.5M +$11.8M +254,711 +316%
Axa
40
Axa
France
$14.9M -$44.8K -966 -0.3%
Morgan Stanley
41
Morgan Stanley
New York
$14.3M -$4.25M -91,766 -23%
Northern Trust
42
Northern Trust
Illinois
$13.8M -$1.82M -39,183 -12%
JPMorgan Chase & Co
43
JPMorgan Chase & Co
New York
$13.7M -$816K -17,616 -6%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$13.4M -$8.45M -182,359 -39%
EMFAT
45
Emerald Mutual Fund Advisers Trust
Pennsylvania
$11.7M +$679K +14,648 +6%
FLAM
46
First Light Asset Management
Minnesota
$10.9M -$10.2M -219,495 -48%
Connor, Clark & Lunn Investment Management (CC&L)
47
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$10.7M +$1.94M +41,773 +22%
Nomura Holdings
48
Nomura Holdings
Japan
$10.6M +$7.32M +157,915 +225%
CSS
49
Cubist Systematic Strategies
Connecticut
$10.4M -$898K -19,380 -8%
Mirae Asset Global Investments
50
Mirae Asset Global Investments
South Korea
$10.4M +$4.27M +92,185 +70%
1
2
3 4 5